Radiation-Induced Cardiac Toxicity After Therapy for Breast Cancer: Interaction Between Treatment Era and Follow-Up Duration

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 4, 2009, Pages 980-987

  Demirci, Senem ^a,b   Nam, Jiho ^c   Hubbs, Jessica L ^c   Nguyen, Thu ^d   Marks, Lawrence B ^b,c  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d IL   (United States)

Author keywords

Breast cancer; Cardiac toxicity; Follow up duration; Radiotherapy; Treatment era

Indexed keywords

PATIENT MONITORING; RADIOTHERAPY;

BREAST CANCER; CARDIAC TOXICITY; FOLLOW-UP DURATION; FRACTION SIZES; KEYWORD SEARCHES; ORTHOVOLTAGE; RANDOMIZED CONTROLLED TRIALS; TREATMENT ERA; UP TIME;

TOXICITY;

ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CARDIOTOXICITY; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIABETES MELLITUS; FOLLOW UP; HEART DISEASE; HUMAN; HYPERTENSION; META ANALYSIS; MORBIDITY; MORTALITY; PRIORITY JOURNAL; SMOKING; SYSTEMATIC REVIEW;

BREAST NEOPLASMS; CLINICAL TRIALS AS TOPIC; FEMALE; FOLLOW-UP STUDIES; HEART; HUMANS; RADIATION INJURIES; TIME FACTORS;

EID: 61349090453     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.11.016     Document Type: Article

References (44)

1. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 (2002) 1233-1241
2. Lichter A.S., Lippman M.E., Danforth Jr. D.N., et al. Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: A randomized trial at the National Cancer Institute. J Clin Oncol 10 (1992) 976-983
3. van Dongen J.A., Voogd A.C., Fentiman I.S., et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 92 (2000) 1143-1150
4. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy: Danish Breast Cancer Cooperative Group 82b trial. N Engl J Med 337 (1997) 949-955
5. Overgaard M., Jensen M.B., Overgaard J., et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353 (1999) 1641-1648
6. Ragaz J., Jackson S.M., Le N., et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337 (1997) 956-962
7. Whelan T.J., Julian J., Wright J., et al. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 18 (2000) 1220-1229
8. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials. Lancet 355 (2000) 1757-1770
9. Cuzick J., Stewart H., Rutqvist L., et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 12 (1994) 447-453
10. Houghton J., Baum M., Haybittle J.L., and The Closed Trials Working Party of the CRC Breast Cancer Trials Group. Role of radiotherapy following total mastectomy in patients with early breast cancer. World J Surg 18 (1994) 117-122
11. Jones J.M., and Ribeiro G.G. Mortality patterns over 34 years of breast cancer patients in a clinical trial of post-operative radiotherapy. Clin Radiol 40 (1989) 204-208
12. Rutqvist L.E., Lax I., Fornander T., et al. Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys 22 (1992) 887-896
13. Rutqvist L.E., and Johansson H. Mortality by laterality of the primary tumour among 55,000 breast cancer patients from the Swedish Cancer Registry. Br J Cancer 61 (1990) 866-868
14. Paszat L.F., Mackillop W.J., Groome P.A., et al. Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the Surveillance, Epidemiology, and End Results cancer registries. J Clin Oncol 16 (1998) 2625-2631
15. Haybittle J.L., Brinkley D., Houghton J., et al. Postoperative radiotherapy and late mortality: Evidence from the Cancer Research Campaign trial for early breast cancer. BMJ 298 (1989) 1611-1614
16. Nixon A.J., Manola J., Gelman R., et al. No long-term increase in cardiac-related mortality after breast-conserving surgery and radiation therapy using modern techniques. J Clin Oncol 16 (1998) 1374-1379
17. Paszat L.F., Vallis K.A., Benk V.M., et al. A population-based case-cohort study of the risk of myocardial infarction following radiation therapy for breast cancer. Radiother Oncol 82 (2007) 294-300
18. Doyle J.J., Neugut A.I., Jacobson J.S., et al. Radiation therapy, cardiac risk factors, and cardiac toxicity in early-stage breast cancer patients. Int J Radiat Oncol Biol Phys 68 (2007) 82-93
19. Darby S.C., McGale P., Taylor C.W., et al. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: Prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 6 (2005) 557-565
20. Reinders J.G., Heijmen B.J., Olofsen-van Acht M.J., et al. Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up. Radiother Oncol 51 (1999) 35-42
21. Darby S., McGale P., Peto R., et al. Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: Nationwide cohort study of 90 000 Swedish women. BMJ 326 (2003) 256-257
22. Harris E.E., Correa C., Hwang W.T., et al. Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. J Clin Oncol 24 (2006) 4100-4106
23. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 366 (2005) 2087-2106
24. Perez C.A., and Halperin E.C. Principles and practice of radiation oncology. 4th ed. (2004), Lippincott Williams & Wilkins, Philadelphia
25. Sheskin D. Handbook of parametric and nonparametric statistical procedures. 4th ed. (2007), Chapman & Hall/CRC, Boca Raton, FL
26. Katz M.H. Multivariable analysis: A practical guide for clinicians. 2nd ed. (2006), Cambridge University Press, Cambridge
27. Davies H.T., Crombie I.K., and Tavakoli M. When can odds ratios mislead?. BMJ 316 (1998) 989-991
28. Altman D.G., Deeks J.J., and Sackett D.L. Odds ratios should be avoided when events are common. BMJ 317 (1998) 1318
29. Szklo M., and Nieto F.J. Epidemiology: Beyond the basics (2000), Aspen, Gaithersburg, MD
30. Patt D.A., Goodwin J.S., Kuo Y.F., et al. Cardiac morbidity of adjuvant radiotherapy for breast cancer. J Clin Oncol 23 (2005) 7475-7482
31. Giordano S.H., Kuo Y.F., Freeman J.L., et al. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 97 (2005) 419-424
32. Gyenes G., Rutqvist L.E., Liedberg A., et al. Long-term cardiac morbidity and mortality in a randomized trial of pre- and postoperative radiation therapy versus surgery alone in primary breast cancer. Radiother Oncol 48 (1998) 185-190
33. Hojris I., Overgaard M., Christensen J.J., et al., Radiotherapy Committee of the Danish Breast Cancer Cooperative Group. Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: Analysis of DBCG 82b and 82c randomised trials. Lancet 354 (1999) 1425-1430
34. Rutqvist L.E., Liedberg A., Hammar N., et al. Myocardial infarction among women with early-stage breast cancer treated with conservative surgery and breast irradiation. Int J Radiat Oncol Biol Phys 40 (1998) 359-363
35. Pinder M.C., Duan Z., Goodwin J.S., et al. Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer. J Clin Oncol 25 (2007) 3808-3815
36. Roychoudhuri R., Robinson D., Putcha V., et al. Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: A population-based study. BMC Cancer 7 (2007) 9
37. Paszat L.F., Mackillop W.J., Groome P.A., et al. Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: A population-based study in Ontario, Canada. Int J Radiat Oncol Biol Phys 43 (1999) 755-762
38. Hooning M.J., Aleman B.M., van Rosmalen A.J., et al. Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study. Int J Radiat Oncol Biol Phys 64 (2006) 1081-1091
39. Hooning M.J., Botma A., Aleman B.M., et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst 99 (2007) 365-375
40. Borger J.H., Hooning M.J., Boersma L.J., et al. Cardiotoxic effects of tangential breast irradiation in early breast cancer patients: The role of irradiated heart volume. Int J Radiat Oncol Biol Phys 69 (2007) 1131-1138
41. Host H., Brennhovd I.O., and Loeb M. Postoperative radiotherapy in breast cancer-Long-term results from the Oslo study. Int J Radiat Oncol Biol Phys 12 (1986) 727-732
42. Vallis K.A., Pintilie M., Chong N., et al. Assessment of coronary heart disease morbidity and mortality after radiation therapy for early breast cancer. J Clin Oncol 20 (2002) 1036-1042
43. Marhin W., Wai E., and Tyldesley S. Impact of fraction size on cardiac mortality in women treated with tangential radiotherapy for localized breast cancer. Int J Radiat Oncol Biol Phys 69 (2007) 483-489
44. Gyenes G., Fornander T., Carlens P., et al. Morbidity of ischemic heart disease in early breast cancer 15-20 years after adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 28 (1994) 1235-1241